4 ms·
It's not like pharmaceutical companies are strapped for cash. If they don't invest in R+D it's a choice.
by alexgmcm 8y ago
It's not like pharmaceutical companies are strapped for cash.
If they don't invest in R+D it's a choice.
- dnautics 8y agoWhy should they invest in r&d when someone like alphabet will do it for them?
- melling 8y agoI believe they do spend a lot of money on R&D. Someone came along with a new idea and applied it to their field. Now that Alphabet has sown them a better way, money should pour into the new technique.
- dnautics 8y agoWhile big pharma does do internal r&d, de facto, new drugs and drug strategies largely come by letting the government fund researchers (typically professors at large research institutes), encouraging these professors to do a spin-off (I deliberately don't want to use "startup") to absorb the scientific risk, followed by an acquisition for IP.
- throwawaylolx 8y agoSure, but I'd be surprised to see a pharmaceutical company profitably competing for talent with FAANG in the race of hiring top ML scientists.